Sesen Bio Inc. [NASDAQ: SESN] closed the trading session at $1.32 on 12/21/20. The day’s price range saw the stock hit a low of $1.29, while the highest price level was $1.70. The company report on December 21, 2020 that Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review.
BLA supported by strong Phase 3 VISTA trial data and positive analytical comparability data.
Priority Review requested with potential approval in mid-2021.
The stocks have a year to date performance of 26.92 percent and weekly performance of -21.89 percent. The stock has been moved at 80.82 percent over the last six months. The stock has performed 14.78 percent around the most recent 30 days and changed -5.71 percent over the most recent 3-months.
If compared to the average trading volume of 2.54M shares, SESN reached to a volume of 13444302 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sesen Bio Inc. [SESN]:
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.14, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 15.07.
SESN stock trade performance evaluation
Sesen Bio Inc. [SESN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.89. With this latest performance, SESN shares gained by 14.78% in over the last four-week period, additionally plugging by 80.82% over the last 6 months – not to mention a rise of 48.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 43.27, with the RSI for the last a single of trading hit 35.14, and the three-weeks RSI is set at 47.51 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 1.2590, while it was recorded at 1.6560 for the last single week of trading, and 0.9380 for the last 200 days.
Sesen Bio Inc. [SESN]: An insightful look at the core fundamentals
Return on Total Capital for SESN is now -421.21, given the latest momentum, and Return on Invested Capital for the company is -1,228.08. Return on Equity for this stock declined to -1,228.08, with Return on Assets sitting at -95.16.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$4,300,000 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.10.
Earnings per share (EPS) analysis for Sesen Bio Inc. [SESN] stock
With the latest financial reports released by the company, Sesen Bio Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.08/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -300.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
Sesen Bio Inc. [SESN]: Insider Ownership positions
There are presently around $30 million, or 17.90% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: TRV GP, LLC with ownership of 4,841,591, which is approximately 0% of the company’s market cap and around 0.06% of the total institutional ownership; VANGUARD GROUP INC, holding 4,700,135 shares of the stock with an approximate value of $6.2 million in SESN stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $2.66 million in SESN stock with ownership of nearly 57.806% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 26 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 5,035,402 shares. Additionally, 12 investors decreased positions by around 931,345 shares, while 11 investors held positions by with 17,098,615 shares. The mentioned changes placed institutional holdings at 23,065,362 shares, according to the latest SEC report filing. SESN stock had 8 new institutional investments in for a total of 749,709 shares, while 4 institutional investors sold positions of 258,866 shares during the same period.